AvidBiotics Corp-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:AvidBiotics Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011848
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AvidBiotics Corp (AvidBiotics) is a healthcare company that develops non-antibody proteins targeting cancer, bacteria and virus-infected cells. The company develops a portfolio of therapeutic protein candidates and protein engineering platforms which include avidocin proteins, mica-body proteins and purocin proteins. Its avidocin proteins are used in treatment of antibiotic-resistant bacterial infections and microbiota management diseases. The company’s mica-body proteins are used in immune oncology applications and treatment of viral infections. Its therapeutic proteins are designed to selectively destroy target cells with laser precision. AvidBiotics is headquartered in San Francisco, California, the US.

AvidBiotics Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AvidBiotics Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
AvidBiotics Corp, Medical Devices Deals, 2011 to YTD 2017 9
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
AvidBiotics Raises Additional US$0.25 Million In Venture Financing 11
Partnerships 12
AvidBiotics Enters Into Research Agreement With Full Spectrum Genetics 12
Licensing Agreements 13
AvidBiotics Enters Into Co-Development Agreement With DuPont Nutrition To Develop Antibacterial Technology For Food Safety 13
AvidBiotics Corp – Key Competitors 14
AvidBiotics Corp – Key Employees 15
AvidBiotics Corp – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Strategy And Business Planning 17
Nov 01, 2017: AvidBiotics Splits into Two Biotechnology Companies Each Developing its Distinct Technology Platform 17
Government and Public Interest 19
Jan 12, 2016: New NIH awards will support development of therapeutic alternatives to traditional antibiotics 19
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
AvidBiotics Corp, Pharmaceuticals & Healthcare, Key Facts 2
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AvidBiotics Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AvidBiotics Corp, Deals By Therapy Area, 2011 to YTD 2017 8
AvidBiotics Corp, Medical Devices Deals, 2011 to YTD 2017 9
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
AvidBiotics Raises Additional US$0.25 Million In Venture Financing 11
AvidBiotics Enters Into Research Agreement With Full Spectrum Genetics 12
AvidBiotics Enters Into Co-Development Agreement With DuPont Nutrition To Develop Antibacterial Technology For Food Safety 13
AvidBiotics Corp, Key Competitors 14
AvidBiotics Corp, Key Employees 15

★海外企業調査レポート[AvidBiotics Corp-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fujifilm Corp:医療機器:M&Aディール及び事業提携情報
    Summary Fujifilm Corp (Fujifilm), a subsidiary of Fujifilm Holdings Corporation, is a provider of imaging and information solutions. The company’s product portfolio encompasses color films, optical devices, digital cameras, photofinishing equipment and color paper, chemicals and services for photofi …
  • Buy It Direct Ltd:企業の戦略的SWOT分析
    Buy It Direct Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Zenkyoren:企業の戦略・SWOT・財務分析
    Zenkyoren - Strategy, SWOT and Corporate Finance Report Summary Zenkyoren - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Black River Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Black River Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Albireo Pharma Inc (ALBO):製薬・医療:M&Aディール及び事業提携情報
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., focuses on the development and commercialization of innovative bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and diseases where inappropriate flow of bile causes severe med …
  • Univalor Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Univalor Inc (Univalor) is a university technology transfer organization that optimizes research outcomes by commercializing the technological innovations of researchers from health centers and academic institutions. The organization provides researcher services such as protecting intellectu …
  • Nedbank Group Ltd (NED):企業の財務・戦略的SWOT分析
    Nedbank Group Ltd (NED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Max Delbruck Center for Molecular Medicine:製薬・医療:M&Aディール及び事業提携情報
    Summary Max Delbruck Center for Molecular Medicine (MDC) is a biomedical research center that offers translating discoveries from molecular research into applications. The company’s research area services offer for cancer research, cardiovascular and metabolic disease, diseases of the nervous system …
  • Repros Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Repros Therapeutics Inc (Repros), formerly Zonagen Inc, a subsidiary of Allergan PLC, is a biopharmaceutical company that develops and markets drugs to treat hormonal and reproductive system disorders. The company’s pipeline product includes enclomiphene and proellex. Its enclomiphene is an …
  • Greenphire Inc:医療機器:M&Aディール及び事業提携情報
    Summary Greenphire Inc (Greenphire) is a provider of clinical trial payment solutions that offers patients reimbursement and site payments. The company’s products portfolio includes ClinCard, ConneXTS and eClinicalGPS. Its eClinicalGPS is a global site that facilitates accurate payment calculation, …
  • Autoliv Inc (ALV):企業の財務・戦略的SWOT分析
    Autoliv Inc (ALV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sumitomo Corporation:企業の戦略・SWOT・財務分析
    Sumitomo Corporation - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Statewide Superannuation Pty Ltd:企業の戦略的SWOT分析
    Statewide Superannuation Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Origin Enterprises PLC:企業のM&A・事業提携・投資動向
    Origin Enterprises PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Origin Enterprises PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Mercer International Inc (MERC):企業の財務・戦略的SWOT分析
    Mercer International Inc (MERC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • AIA Group Limited:戦略・SWOT・企業財務分析
    AIA Group Limited - Strategy, SWOT and Corporate Finance Report Summary AIA Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • RWE AG (RWE):電力:M&Aディール及び事業提携情報
    Summary RWE AG (RWE) is an energy company. It has presence in the energy value chain, from lignite production and electricity generation, to energy trading and operation of distribution networks, and supply of electricity, gas and energy solutions. The company produces electricity using conventional …
  • OSRAM Opto Semiconductors GmbH:企業の戦略的SWOT分析
    OSRAM Opto Semiconductors GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • BAM Nuttall Ltd:企業の戦略的SWOT分析
    BAM Nuttall Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • BioInvent International AB (BINV):企業の財務・戦略的SWOT分析
    BioInvent International AB (BINV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆